Cell, gene, and tissue therapies offer unprecedented opportunities to both biotechnology companies and life-science investors. However, the road to commercialization for these therapies is largely unmapped. PharmaNet Consulting professionals provide expert guidance on predicting commercial feasibility, complying with GMP guidelines and evolving regulatory requirements, controlling biomaterial sources, and analyzing key issues in business opportunities.
PharmaNet professionals available for consultation on this topic include:
Executive Director, PharmaNet Consulting
Joyce Lea Frey-Vasconcells, PhD
Executive Director, PharmaNet Consulting
504 Carnegie Center, Princeton, NJ 08540